Evidence map›Paper›PMID 40415956›Full record

ArticleFrontiers in cellular and infection microbiology2025

Rashmi Gupta, Martin Schuster, Kyle H Rohde

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Co-infection withFrontiers in medicine · 2026
    Review
  3. Frontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rashmi GuptaDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Martin SchusterDivision of Microbiology, College of Science, Oregon State University, Corvallis, OR, United States.
Kyle H RohdeDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic bacterial infections are responsible for significant morbidity and mortality in cystic fibrosis (CF) patients. Methods: To address this knowledge gap, the study examined how Results: In initial studies, we noted that the growth of Discussion: The study showed

Indexed as

AntibiosisMicrobial InteractionsMycobacterium abscessusMycobacterium Infections, NontuberculousPersistent InfectionPseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsBacterial ProteinsCoculture TechniquesCoinfectionCystic FibrosisHumansQuorum SensingAnti-Bacterial AgentsBacterial Proteinsdual RNAseqmixed microbial interactionsMycobacterium abscessusPseudomonas aeruginosaquorum sensingsecreted factors

Identifiers

PMID40415956
PMCPMC12098619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.